Show simple item record

dc.contributor.authorLione, Lisa
dc.contributor.authorCarter, R. J.
dc.contributor.authorHunt, M. J.
dc.contributor.authorBates, G. P.
dc.contributor.authorMorton, A. J.
dc.contributor.authorDunnett, S B
dc.date.accessioned2013-07-03T15:17:04Z
dc.date.available2013-07-03T15:17:04Z
dc.date.issued1999-12-01
dc.identifier.citationLione , L , Carter , R J , Hunt , M J , Bates , G P , Morton , A J & Dunnett , S B 1999 , ' Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation ' , Journal of Neuroscience , vol. 19 , no. 23 , pp. 10428-10437 .
dc.identifier.issn0270-6474
dc.identifier.urihttp://hdl.handle.net/2299/11080
dc.description.abstractCognitive decline is apparent in the early stages of Huntington's disease and progressively worsens throughout the course of the disease. Expression of the human Huntington's disease mutation in mice (R6/2 line) causes a progressive neurological phenotype with motor symptoms resembling those seen in Huntington's disease. Here we describe the cognitive performance of R6/2 mice using four different tests (Morris water maze, visual cliff avoidance, two-choice swim tank, and T-maze). Behavioral testing was performed on R6/2 transgenic mice and their wild-type littermates between 3 and 14.5 weeks of age, using separate groups of mice for each test. R6/2 mice did not show an overt motor phenotype until similar to 8 weeks of age. However, between 3.5 and 8 weeks of age, R6/2 mice displayed progressive deterioration in specific aspects of learning in the Morris water maze, visual cliff, two-choice swim tank, and T-maze tasks. The age of onset and progression of the deficits in the individual tasks differed depending on the particular task demands. Thus, as seen in humans with Huntington's disease, R6/2 mice develop progressive learning impairments on cognitive tasks sensitive to frontostriatal and hippocampal function. We suggest that R6/2 mice provide not only a model for studying cognitive and motor changes in trinucleotide repeat disorders, but also a framework within which the functional efficacy of therapeutic strategies aimed at treating such diseases can be tested.en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofJournal of Neuroscience
dc.subjecttransgenic mice
dc.subjectHuntington's disease
dc.subjectcognition
dc.subjectbehavior
dc.subjectMorris water maze
dc.subjectT-maze
dc.subjectTOXIN 3-NITROPROPIONIC ACID
dc.subjectTRANSGENIC MICE
dc.subjectSYNAPTIC PLASTICITY
dc.subjectQUINOLINIC ACID
dc.subjectDEFICITS
dc.subjectMODEL
dc.subjectDYSFUNCTION
dc.subjectSTRIATUM
dc.subjectLESIONS
dc.subjectMEMORY
dc.titleSelective discrimination learning impairments in mice expressing the human Huntington's disease mutationen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionTRP Ion channels
dc.contributor.institutionCentre for Research in Mechanisms of Disease and Drug Discovery
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionBasic and Clinical Science Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.description.statusPeer reviewed
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record